BR112014009223A2 - método para o diagnóstico da doença de niemann-pick - Google Patents

método para o diagnóstico da doença de niemann-pick

Info

Publication number
BR112014009223A2
BR112014009223A2 BR112014009223A BR112014009223A BR112014009223A2 BR 112014009223 A2 BR112014009223 A2 BR 112014009223A2 BR 112014009223 A BR112014009223 A BR 112014009223A BR 112014009223 A BR112014009223 A BR 112014009223A BR 112014009223 A2 BR112014009223 A2 BR 112014009223A2
Authority
BR
Brazil
Prior art keywords
niemann
pick disease
diagnosis
subject
pick
Prior art date
Application number
BR112014009223A
Other languages
English (en)
Other versions
BR112014009223B1 (pt
BR112014009223A8 (pt
Inventor
Rolfs Arndt
Masch Hermann
Original Assignee
Centogene Ag
Pharm-Analyt Labor Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centogene Ag, Pharm-Analyt Labor Gmbh filed Critical Centogene Ag
Publication of BR112014009223A2 publication Critical patent/BR112014009223A2/pt
Publication of BR112014009223A8 publication Critical patent/BR112014009223A8/pt
Publication of BR112014009223B1 publication Critical patent/BR112014009223B1/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

resumo patente de invenção: "método para o diagnóstico da doença de niemann-pick". a presente invenção refere-se a um método para o diagnóstico da doença de niemann-pick em um sujeito compreendendo uma etapa a), em que a etapa a) compreende detecção de um biomarcador em uma amostra do sujeito.
BR112014009223-0A 2011-11-15 2012-11-15 Métodos para o diagnóstico da doença de niemann-pick, método para determinação do curso da doença de niemann-pick, método para determinação da eficácia de pelo menos um tratamento, uso de análise espectrométrica de massa e kit BR112014009223B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11009062 2011-11-15
EP11009062.8 2011-11-15
PCT/EP2012/004756 WO2013072060A2 (en) 2011-11-15 2012-11-15 Method for the diagnosis of niemann-pick disease

Publications (3)

Publication Number Publication Date
BR112014009223A2 true BR112014009223A2 (pt) 2017-06-13
BR112014009223A8 BR112014009223A8 (pt) 2017-06-20
BR112014009223B1 BR112014009223B1 (pt) 2021-04-06

Family

ID=47221301

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014009223-0A BR112014009223B1 (pt) 2011-11-15 2012-11-15 Métodos para o diagnóstico da doença de niemann-pick, método para determinação do curso da doença de niemann-pick, método para determinação da eficácia de pelo menos um tratamento, uso de análise espectrométrica de massa e kit

Country Status (11)

Country Link
US (4) US9910033B2 (pt)
EP (1) EP2780716B1 (pt)
JP (2) JP6243846B2 (pt)
AU (3) AU2012339149A1 (pt)
BR (1) BR112014009223B1 (pt)
CA (1) CA2854668A1 (pt)
CY (1) CY1122360T1 (pt)
DK (1) DK2780716T3 (pt)
IL (1) IL231982B (pt)
MX (1) MX359328B (pt)
WO (1) WO2013072060A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9983200B2 (en) 2013-03-14 2018-05-29 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
SG11201509622WA (en) * 2013-06-07 2015-12-30 Genzyme Corp Marker for acid sphingomyelinase disorders and uses thereof
CA3002526A1 (en) 2014-10-28 2016-05-06 Washington University Bile acid biomarkers for niemann-pick diseases, methods and uses therefor
EP3221705A1 (en) * 2014-11-19 2017-09-27 Centogene AG Method for the diagnosis of niemann-pick disease using a biomarker
US10656059B2 (en) 2018-03-07 2020-05-19 Alcala Pharmaceutical, Inc. Method for qualitative and quantitative multiplexing of drug analytes from biological samples
EP3803412A1 (en) * 2018-06-01 2021-04-14 Laboratory Corporation of America Holdings Simplified biosample processing for lc-ms/ms
CN111289647A (zh) * 2020-03-09 2020-06-16 广州市妇女儿童医疗中心（广州市妇幼保健院、广州市儿童医院、广州市妇婴医院、广州市妇幼保健计划生育服务中心） 葡糖鞘氨醇的检测方法
WO2024026390A2 (en) * 2022-07-28 2024-02-01 Wylder Nation Foundation Compositions and methods for diagnosing, treating, and preventing lysosomal storage diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4498918B2 (ja) * 2002-04-30 2010-07-07 生化学工業株式会社 リソソーム病の検出方法
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
US8313949B2 (en) 2009-04-16 2012-11-20 Nextcea Inc. Detecting phospholipidosis and diagnosing lysosomal storage disorders
KR20230164773A (ko) 2009-08-28 2023-12-04 이칸 스쿨 오브 메디슨 엣 마운트 시나이 산성 스핑고미엘리나제 결핍을 치료하기 위한 투여량 단계적 증가 효소 대체 요법

Also Published As

Publication number Publication date
AU2021204429A1 (en) 2021-07-29
AU2021204429B2 (en) 2024-01-25
AU2018229451A1 (en) 2018-10-04
CA2854668A1 (en) 2013-05-23
US20140309140A1 (en) 2014-10-16
US10422789B2 (en) 2019-09-24
MX2014005923A (es) 2014-09-08
CY1122360T1 (el) 2021-01-27
US11841362B2 (en) 2023-12-12
US20220187283A1 (en) 2022-06-16
AU2012339149A1 (en) 2014-04-24
JP2018054620A (ja) 2018-04-05
US9910033B2 (en) 2018-03-06
AU2018229451B2 (en) 2021-04-01
US11231412B2 (en) 2022-01-25
US20200072819A1 (en) 2020-03-05
JP6711807B2 (ja) 2020-06-17
JP6243846B2 (ja) 2017-12-06
DK2780716T3 (da) 2019-10-14
EP2780716B1 (en) 2019-07-31
US20180088107A1 (en) 2018-03-29
WO2013072060A2 (en) 2013-05-23
BR112014009223B1 (pt) 2021-04-06
MX359328B (es) 2018-09-25
IL231982B (en) 2020-01-30
EP2780716A2 (en) 2014-09-24
AU2012339149A8 (en) 2014-05-08
WO2013072060A8 (en) 2014-07-17
JP2014533367A (ja) 2014-12-11
BR112014009223A8 (pt) 2017-06-20
WO2013072060A3 (en) 2013-07-25
IL231982A0 (en) 2014-05-28

Similar Documents

Publication Publication Date Title
BR112014009223A2 (pt) método para o diagnóstico da doença de niemann-pick
EA201590027A1 (ru) Способы детекции заболеваний или состояний
BR112014010955A2 (pt) sistema e método para processar amostras
CL2013001883A1 (es) Metodo de inmunoensayo para vitamina d; inmunoensayo para detectar vitamina 25-oh d en sangre.
BR112015018463A2 (pt) Biomarcadores de diabetes tipo 2 e usos dos mesmos
BR112014009643A2 (pt) métodos para diagnosticar ou detectar neoplasia colorretal em um sujeito humano, biomarcador para progressão de doença e kits para um diagnóstico de neoplasia colorretal
BRPI1009343A2 (pt) método realizado por hardware que executa software, e, mídia legível por computador não temporária
BR112013023540A2 (pt) anticorpo, kit e método para a determinação de peptídeos amilóides
BR112012030587A2 (pt) métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador
AR088083A1 (es) USO DE ANTICUERPOS DE UNION A IL-1b
BR112015014232A2 (pt) lesão renal aguda
BR112013026482A2 (pt) captura de amostra em uma única etapa para tiras de teste
EA201591742A1 (ru) Способ улучшения диагностики заболеваний с использованием измеряемых аналитов
WO2013023144A3 (en) Diagnostic biomarker profiles for the detection and diagnosis of parkinsons disease
CR20110530A (es) Dispositivo y procedimiento para la verificación y para el análisis cuantitativo de analitos, particularmente de micotoxinas
WO2015013508A3 (en) Methods for diagnosing and treating immune disease
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
BR112013031431A2 (pt) método para o diagnóstico da doença de gaucher
GB201201766D0 (en) Method
BR112015027249A2 (pt) método de diagnóstico de câncer
BR112017027304A2 (pt) método para o diagnóstico de doença de farber
GB201114909D0 (en) Biomarkers for lysosomal storage disorders
BR112015013498A2 (pt) método para o diagnóstico de leucodistrofia metacromática
BR112014006296A2 (pt) método para detectar um analito
BR112012007557A2 (pt) alterações anormais de processamento de isozimas de pkc em células periféricas da doença de alzheimer

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: CENTOGENE AG (DE)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: CENTOGENE AG (DE)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: CENTOGENE GMBH (DE)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/11/2012, OBSERVADAS AS CONDICOES LEGAIS.